Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapFalling Star
    All News

    Brief: Epkinly® (Epcoritamab) Approved By Japan Ministry Of Health, Labour And Welfare For Additional Indication As A Treatment For Relapsed Or Refractory Follicular Lymphoma

    Picture of Genmab A/S logoGenmab A/S
    20/02/2025 13:01
    Feb 20 (Reuters) - Genmab A/S  GMAB.CO :
    * EPKINLY® (EPCORITAMAB) APPROVED BY JAPAN MINISTRY OF
HEALTH,
LABOUR AND WELFARE FOR ADDITIONAL INDICATION AS A TREATMENT FOR
RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

Source text:  ID:nBw9HmQW8a 
Further company coverage:  GMAB.CO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Genmab A/S

    See all news